RALEIGH, N.C., Dec. 11 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of a new office in Mexico City, Mexico. With years of long-standing South American operations, PRA entered the Mexico market in 2005. The region's existing base of clinical sites with expertise in oncology, cardiovascular, CNS and infectious diseases match favorably to PRA's therapeutic focus. The expansion is also advantageous for PRA and its clients given Mexico's reliable regulatory timelines and the ability to run placebo trials.
The new PRA location provides proximity to the large population center of Mexico City, easy access to the Ministry of Health, and the ability to oversee trials in Central America. The facility is home to more than 20 clinical staff, with room to expand to nearly 50 as trial volume in the region increases.
"We are pleased to formalize our operations in Mexico with a new facility," commented Charles Schmidt, Senior Director of Operations for Latin America. "Mexico is a country with a strong tradition in clinical trials. It will also help open the door for further expansion into Central America."
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 32 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.
|SOURCE PRA International|
Copyright©2008 PR Newswire.
All rights reserved